Navigation Links
BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
Date:10/28/2008

hts were extended to include Taiwan. In 2007, BioCryst received a $14 million up-front payment and may also receive future clinical event milestone payments (up to $21 million) and commercial event milestone payments (up to $95 million) in addition to double-digit (between 10 percent and 20 percent range) royalty payments on product sales of peramivir. BioCryst retains all rights to commercialize peramivir in North America, Europe and other countries outside of Japan, Taiwan and Korea.

About Peramivir

Peramivir is an antiviral agent that inhibits the interactions of influenza neuraminidase, an enzyme which is critical to the spread of influenza within a host. In laboratory tests, peramivir has shown activity against viral strains that are resistant to currently available treatments and has been safely administered to healthy subjects at high dose levels. Peramivir is currently being studied in hospitalized and outpatient influenza, utilizing either an intramuscular or intravenous formulation. A Phase 2 trial in outpatient influenza is currently ongoing, a Phase 2 trial in hospitalized influenza was recently completed and BioCryst's partner, Shionogi & Co., Ltd. is preparing for a pivotal Phase 3 trial of peramivir in outpatient influenza.

About Shionogi & Co., Ltd.

Shionogi & Co., Ltd., one of Japan's largest research-based pharmaceutical companies develops, manufactures, distributes, imports and exports pharmaceuticals and diagnostics. Shionogi aims to provide innovative medicines which make a positive contribution to world-wide health. For additional company information, please visit Shionogi on the World Wide Web at http://www.shionogi.co.jp.

About BioCryst

BioCryst is an integrated biopharmaceutical company utilizing crystallography and structure-based drug design to develop a deep pipeline of novel therapeutics targeting major illnesses. BioCryst is currently advanci
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
2. BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
3. Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008
4. LCA-Vision Reports Third Quarter 2008 Financial Results
5. Universal Health Services, Inc. Reports 2008 Third Quarter Results
6. PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results
7. Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009
8. WellPoint Reports Third Quarter 2008 Results
9. Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80
10. Schering-Plough Reports Financial Results for Third Quarter of 2008
11. Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... CA (PRWEB) March 31, 2015 Over ... robotic hair transplant technique have yielded better results ... , when refined and perfected by a good hair ... the most advanced techniques of hair restoration have improved ... can still be used to add precision and flexibility ...
(Date:3/31/2015)... In conjunction with the Asbestos ... the Mesothelioma Applied Research Foundation (Meso Foundation) announced ... complement its existing work in mesothelioma research, education, ... the Meso Foundation’s mission, we want to eliminate ... to asbestos, including mesothelioma,” said the Meso Foundation’s ...
(Date:3/31/2015)... Nashua, NH (PRWEB) March 31, 2015 ... Class of 2015 at Rivier University’s Commencement ... honorary doctorate of humane letters in recognition of her ... educator. , Serving as a front-line caregiver and senior ... for 25 years and advancing to leadership roles, including ...
(Date:3/31/2015)... Many people, including the ones with physical challenges, ... are only for able-bodied participants. , A new ... to change that thinking. , The program, part ... Sports Expo on Saturday, April 11 (10 a.m. to ... , The event will showcase a wide variety ...
(Date:3/31/2015)... 2015 OnChip Devices , a world ... silicon ESD diode chip targeted towards low voltage LED applications. ... Zeners are ideal for protecting circuits by suppressing voltage higher ... handle pulses of up to 350W and 20A, providing protection ... 61000-4-2 standard. These diodes do not exhibit any device ...
Breaking Medicine News(10 mins):Health News:Beverly Hills Hair Transplant Surgeon Now Combines Advanced Robotic Hair Transplantation and Manual Techniques for Greatest Results 2Health News:Mesothelioma Research Organization Announces New Prevention Program 2Health News:Mesothelioma Research Organization Announces New Prevention Program 3Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 3Health News:Memorial Healthcare System's Adaptive Sports Expo Encourages Physically Challenged To Go Beyond Perceived Limitations 2Health News:OnChip Introduces Low Voltage Diodes for High-Brightness LED Protection 2
... April 11 Samplify Systems, Inc., a,real-time ... Samplify for Windows Release 2.6 and Samplify ... the same compression and,decompression engine as the ... user application development through an applications,programming interface ...
... ARBOR, Mich. Every day, thousands of doctors around the ... help patients in pain -- and the risk of abetting ... medical license for doing so. , They walk this ... a powerful opioid narcotic painkiller, such as Oxycontin or Vicodin. ...
... Physician Assistant among top 10 white-collar jobs to ... The American,Academy of Physician Assistants (AAPA) applauds ... careers to have in a recession",list the personal ... took the Bureau of Labor Statistics, 2008 list ...
... 10 Microflex Corporation, a leader in,the development ... of Barrier Safe Solutions International, launches the newest,addition ... Tranquility(TM), a white,examination glove that offers the ideal ... conform to the hand allowing for exceptional,tactile sensitivity ...
... of $350K will Target Easter Seals Affiliates Nationwide, ... the emerging,challenges of people living with autism during April,s ... $350,000 in grants this,month from the CVS Caremark Charitable ... million to support Easter Seals autism services,nationwide. These grants ...
... A new report from Packaged Facts,Pet Insurance in ... interest in pet insurance during the next five years,placing ... forecast is consistent,with soaring revenues in the overall pet ... more on the health and wellness of their,beloved furry ...
Cached Medicine News:Health News:Samplify Systems Announces Availability of Samplify for Windows Release 2.6, and Samplify for Windows Embedded Edition, Transforming RF Data Recording Applications with X-COM Systems 2Health News:Samplify Systems Announces Availability of Samplify for Windows Release 2.6, and Samplify for Windows Embedded Edition, Transforming RF Data Recording Applications with X-COM Systems 3Health News:Study shows doctor's offices can help stem abuse of Oxycontin, other narcotic painkillers 2Health News:Study shows doctor's offices can help stem abuse of Oxycontin, other narcotic painkillers 3Health News:Study shows doctor's offices can help stem abuse of Oxycontin, other narcotic painkillers 4Health News:Money Magazine Ranks Physician Assistant One of Best Careers to Have in a Recession 2Health News:Microflex Introduces Tranquility(TM) White Nitrile Gloves 2Health News:Easter Seals Receives $1 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children 2Health News:Easter Seals Receives $1 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children 3Health News:North America Primed for Pet Insurance Market Expansion and Expecting $1.1 Billion by 2012 2
(Date:3/31/2015)... -- Ryan & Maniskas, LLP is investigating ... Therapeutics, Inc. ("Hyperion" or the "Company") (NASDAQ: HPTX ... violations of law related to the Company,s efforts to ... transaction valued at approximately $1.1 billion. If ... learn more about this class action or if you ...
(Date:3/31/2015)... March 31, 2015 Medela has announced ... and Invia ® Motion™-Endure personal pumps to ... and services. These new devices, along with the ... commitment to provide innovative, high-quality NPWT solutions, designed ... to patients. "We are happy to ...
(Date:3/31/2015)...   Halyard Health (NYSE: HYH ), ... a new purchasing agreement with HealthTrust for ... 2015, Halyard,s standard and ASTM-rated face masks , ... available to HealthTrust members made up of 1,350 acute ... physician practices and alternate care facilities. ...
Breaking Medicine Technology:Ryan & Maniskas, LLP Announces Investigation of Hyperion Therapeutics, Inc. 2Medela Launches Product Line to Support Individualized Care For Negative Pressure Wound Therapy Patients 2Halyard Health Signs First GPO Contracts As Independent Company 2Halyard Health Signs First GPO Contracts As Independent Company 3
... CHADDS FORD, Pa., Oct. 27, 2011 ... prior year; branded pharmaceuticals revenues grow 17 Percent, reflecting strong performance ... Reported quarterly diluted EPS of $0.34 versus $0.46 for prior ... reflecting growth of 45 percent from 2010 ...
... PITTSBURGH, Oct. 27, 2011 Mylan Inc. (Nasdaq: ... has received final approval from the U.S. Food and Drug ... Morphine Sulfate Extended-release (ER) Tablets, 15 mg, 30 mg, 60 ... Purdue Pharma,s MS Contin ® , an opioid analgesic for ...
Cached Medicine Technology:Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 2Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 3Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 4Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 5Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 6Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 7Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 8Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 9Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 10Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 11Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 12Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 13Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 14Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 15Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 16Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance 17
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: